• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS NH3L2; ENZYMATIC METHOD, AMMONIA

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS NH3L2; ENZYMATIC METHOD, AMMONIA Back to Search Results
Catalog Number ASKU
Device Problems Incorrect, Inadequate or Imprecise Result or Readings (1535); High Test Results (2457); Non Reproducible Results (4029)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/01/2003
Event Type  malfunction  
Event Description
There was an allegation of questionable plasma nh3l ammonia results for 4 patient samples on a hitachi 917 analyzer.For sample 1, the initial nh3 result was 163 umol/l.The sample was repeated in three 20 minute intervals and the results were 235 umol/l, 292 umol/l, and 315 umol/l.For sample 2, the initial nh3 result was 209 umol/l.The sample was repeated in three 20 minute intervals and the results were 272 umol/l, 351 umol/l, and 383 umol/l.For sample 3, the initial nh3 result was 201 umol/l.The repeat result was 276 umol/l.For sample 4, the initial nh3 result was 259 umol/l.The repeat result was 339 umol/l.
 
Manufacturer Narrative
The analyzer serial number was not provided.The study alleged that antineoplastic therapy with asparaginase can affect ammonia results in plasma samples.The study stated that asparaginase converts the amino acid asparagine to aspartic acid and ammonia and it appears from their observations that some ammonia production occurs in vitro after sample collection.The investigation is ongoing.
 
Manufacturer Narrative
The investigation found that the patient was taking erwinase.Per erwinase labeling, the drug can lead to an increase in ammonia in the blood in 1% of patients.The root cause of the event was found to be consistent with erwinase interference.No product problem was identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NH3L2
Type of Device
ENZYMATIC METHOD, AMMONIA
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhofer strasse 116
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
amy nelson
9115 hague road
indianapolis, IN 46250
MDR Report Key18347471
MDR Text Key331060780
Report Number1823260-2023-04086
Device Sequence Number1
Product Code JIF
Combination Product (y/n)Y
Reporter Country CodeUS
PMA/PMN Number
ASKU
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 02/05/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/18/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberASKU
Device Lot NumberASKU
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/15/2024
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ASPARAGINASE
Patient SexFemale
-
-